If you missed it, this article is part of a short series on the odd debris that collects at the bottom of a brokerage account. Part 1 looked at the portfolio graveyard generally. This time, I want to focus on one of its strangest residents: The contingent value right, or CVR. Quick Answer: A CVR (contingent value right)… Read More »
They Can Check Out Anytime They Want- But They Can Never Leave If you spend enough time investing in nanocaps, microcaps, pink sheets, and special situations, your portfolio develops something unexpected: A basement. Scroll far enough down your brokerage account and you’ll find it – a list of positions that: no longer trade no longer report and, according… Read More »
In which Pooh discovers that crypto honey is gone, an environmental acorn may yet grow, multifamily houses vanish, and the old biotech jars are to be offered for sale. Hundred Acre Nasdaq, August 2025 — Windtree the Pooh (NASDAQ: WINT), a Bear of Very Little Capital but Very Big Announcements, today reported that its crypto treasury adventure… Read More »
In which Windtree(WINT) remembers it is a drug company after all, and says something Clinical before lunch A whimsical tale of finance and pharmaceuticals, as told in the Hundred Acre Nasdaq. One day in the Hundred Acre Nasdaq, Windtree the Pooh awoke to a rather curious thing: A press release. It was early, and quite serious. And… Read More »
🌀 Windtree Update: The BNB Play Moves Closer to Reality—Still No Cash In our previous piece, “Is the Answer Blowing in the Windtree?”, we chronicled Windtree Therapeutics’(WINT) recent run of splashy announcements that sounded transformational—crypto treasury strategy, environmental services acquisitions, asset monetizations—but notably, none of them had actually happened yet. Since that article, only one of those… Read More »
Biglari Holdings(BH) CEO Sardar Biglari has launched another insurgency—this time against Jack in the Box(JACK). Through Biglari Capital, he quietly built a 9.9% stake in the fast-food chain and is now pursuing activist tactics aimed at reshaping the company’s future. But if history is any guide, shareholders should beware: Biglari’s interventions tend to center more on consolidating his… Read More »
Windtree Therapeutics (WINT) has made more announcements in the last six months than many companies do in a decade. But for all the flash and forward-looking language—crypto treasuries, waste management acquisitions, real estate deals, and manufacturing partnerships—there’s one glaring omission: not a single one of these strategies appears to have actually closed, and none are related to… Read More »
I have a few shares of a tiny biotech called Biovie(BIVI) that got much tinier this morning after they released results of a phase 3 Alzheimer’s trial for their NE3107 drug candidate. Trial failures are normal, they happen, and it’s why I have for many years bought biotechs in baskets. However, the company’s announcement of trial results is… Read More »
What’s the smallest publicly traded utility in the US? Though it’s dark and expert market only, I believe the answer is Mt. Carmel Public Utility(MCPB). It is a tiny electric and gas utility serving Mr. Carmel, IL. It traded by appointment prior to the ridiculous SEC reg on dark stocks, and now trades only on the expert market.… Read More »
Is it unremarkable for a company’s CEO, COO and a Director to all resign within a two day period? Steven Kiel seems to think so. Kiel is the largest shareholder and once again CEO of the company formerly known as Sitestar, now known as the boringly generic Enterprise Diversified(SYTE). The company changed its name to reflect its disastrous… Read More »